← Back to Search

PRO data utilized for Rheumatoid Arthritis (PRO Trial)

N/A

Waitlist Available

Led By Michael R Bubb, MD

Research Sponsored by North Florida Foundation for Research and Education

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Summary

The overall goal of this proposal is to address barriers to the use of patient reported outcome (PRO) data in the Dept. of Veterans Affairs (VA) health care system.

Eligible Conditions

Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

physician/lab-derived instruments of clinical efficacy as measured by DAS28 change and DAS28 remission.

Secondary study objectives

medication compliance

patient satisfaction

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: PRO data utilizedExperimental Treatment1 Intervention

PRO data derived from the patient-completed MDHAQ/RAPID3 questionnaire will be collected from this arm and provided to the treating physicians.

Group II: PRO data not utilizedPlacebo Group1 Intervention

PRO data derived from the patient-completed MDHAQ/RAPID3 questionnaire will be collected from this arm but will not be provided to the treating physicians.

Do I qualify?Apply below to find out